Podcast: Play in new window | Download (Duration: 40:54 — 56.2MB) | Embed

Subscribe: Email | RSS

This video is part of a series of guest expert interviews that we recorded for our new Yale Certificate Program on Medical Software and Medical AI – https://online.yale.edu/medical-software-ai-program. Our guest is Eric Henry. Mr. Henry is the Senior Quality Systems & Compliance Advisor at the Law Firm King & Spalding and works from his home in the Cleveland area. He joined King & Spalding in 2018 after 30 years managing global technical and regulatory compliance organizations in various industries and in medical devices in particular over the last 22 years. Eric currently provides advisory and consulting services to corporate management, boards, and staff regarding regulatory compliance, enforcement, and policy matters for regulated life sciences companies. Mr. Henry is a member of the AFDO/RAPS Healthcare Products Collaborative AI Strategic Committee and co-chairs their Good Machine Learning Practices Working Team. He also advises the Coalition for Health AI in their Predictive AI and Assurance Lab Certification Work Groups.

00:10 Introduction. Who is Eric Henry?
06:28 The FDA and AI.
14:45 The state of affairs outside the United States. China and the EU.
19:44 The general state of upheaval in Medical Devices/AI in the EU.
23:44 The current discussion on medical AI at the FDA. Potential issues with a new administration.
29:33 AI Tools development inside Health Systems. Challenges, fears and opportunities
38:34 Concluding Thoughts

Additional Readings:
European Union. Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence [Internet]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202401689

U.S. Food and Drug Administration, Health Canada, Medicine & Helathcare products Regulatory Agency. Good Machine Learning Practice for Medical Device Development. 2021 Oct. Available from: https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles

U.S. Food and Drug Administration, Health Canada, Medicine & Helathcare products Regulatory Agency. Transparency for machine learning-enabled medical devices: Guiding principles. 2024 Jun. Available from: https://www.fda.gov/medical-devices/software-medical-device-samd/transparency-machine-learning-enabled-medical-devices-guiding-principles

U.S. Food and Drug Administration, Health Canada, Medicine & Helathcare products Regulatory Agency. Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles 2023. Available from: https://www.fda.gov/medical-devices/software-medical-device-samd/predetermined-change-control-plans-machine-learning-enabled-medical-devices-guiding-principles

Readings from Mr. Henry’s own work:
AI/ML in Medical Devices: US & EU Regulatory Perspectives (https://array.aami.org/content/news/ai-ml-medical-devices-us-eu-regulatory-perspectives )

Medical Device Cybersecurity for Engineers and Manufacturers, Second Edition (Chapter 3: Global Regulations and Standards) (https://us.artechhouse.com/Medical-Device-Cybersecurity-for-Engineers-and-Manufacturers-Second-Edition-P2416.aspx )

“Bias in Artificial Intelligence In Healthcare Deliverables” (https://healthcareproducts.org/ai/aighi/aio/whitepaper-bias-in-ai-healthcare/ )

Software Under the Regulatory Microscope: The Current and Future State of Enforcement for Regulated Computer Systems (https://www.americanpharmaceuticalreview.com/Featured-Articles/574553-Software-Under-the-Regulatory-Microscope-The-Current-and-Future-State-of-Enforcement-for-Regulated-Computer/ )

You can find a full list of Mr. Henry’s publications, conference presentations, and media interviews on his LinkedIn profile: https://www.linkedin.com/in/eric-henry-519bb48/

Podcast: Play in new window | Download (Duration: 26:48 — 36.9MB) | Embed

Subscribe: Email | RSS

This video is part of a series of guest expert interviews that we recorded for our new Yale Certificate Program on Medical Software and Medical AI – https://online.yale.edu/medical-software-ai-program.

Our guest is Ian Sutcliffe, who is Principal Solutions Architect at AWS. Prior to that he has many years in the health sciences and tech industry in various software roles as both a developer and architect covering the solution, business and enterprise domains. He also serves on the AAMI Working Group that is developing guidance for the use of public cloud services in medical devices. The video was recorded on September 10, 2024.

00:10 Introduction
02:24 Creating a cloud service at “cloud scale.”
07:22 Dealing with changes in cloud software.
11:25 Automating testing and testing in production
15:00 Distributed systems
16:35 Compliance boundaries, medical device functions and computing environment
20:25 Designing with change in mind (non-monolithic systems)
22:17 Migrating existing systems to the cloud
25:41 Concluding thoughts

Links:
Association for the Advancement of Medical Instrumentation (AAMI). AAMI/CR510:2021; Appropriate use of public cloud computing for quality systems and medical devices. 2021. Report No.: CR510. Available from: https://array.aami.org/doi/book/10.2345/9781570208225

Podcast: Play in new window | Download (Duration: 51:36 — 70.9MB) | Embed

Subscribe: Email | RSS

This video is part of a series of guest expert interviews that we recorded for our new Yale Certificate Program on Medical Software and Medical AI – https://online.yale.edu/medical-software-ai-program.

Our guest is Prof Frangi is the Bicentennial Turing Chair in Computational Medicine at the University of Manchester, Manchester, UK, with joint appointments at the Schools of Computer Science and Health Sciences. He is also the Royal Academy of Engineering Chair in Emerging Technologies, with a focus on Precision Computational Medicine for in silico trials of medical devices. He is the Director of the Christabel Pankhurst Institute for Health Technology Research and Innovation (www.pankhurst.manchester.ac.uk). He conducts research in computational medical imaging and computational image-based medicine. Prof Frangi obtained his undergraduate degree in Telecommunications Engineering from the Technical University of Catalonia (Barcelona) in 1996. He pursued his PhD in Medicine at the Image Sciences Institute of the University Medical Centre Utrecht University on model-based cardiovascular image analysis. He leads the InSilicoUK Pro-Innovation Regulations Network (www.insilicouk.org). The video was recorded on July 19, 2024.

00:10 Introduction
10:07 From deep data to deep insights
20:35 Who was Christabel Panhurst?
23:33 In-silico trials: an introduction.
42:30 Regulators and in-silico trials.
50:11 Training people to work in this space and concluding thoughts.
Links
Frangi AF | Machine Learning for Computational Phenomics and In-Silico Trials: https://youtu.be/K8X9T7wSDqE?si=OdV1lRj0T_CZMYaa
Frangi AF | Computational Medicine & Digital Twins Improving Medical Care: https://www.youtube.com/watch?v=afPmHkOjAWo&feature=youtu.be

InSilicoUK Pro-Innovation Regulations Network www.insilicouk.org or join LinkedIn Group https://www.linkedin.com/groups/9169266/

Sarrami-Foroushani A, Lassila T, MacRaild M, Asquith J, Roes KCB, Byrne JV, Frangi AF. In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials. Nat Commun [Internet]. Springer Science and Business Media LLC; 2021 Jun 23 [cited 2022 Aug 19];12(1):3861. Available from: https://www.nature.com/articles/s41467-021-23998-w PMCID: PMC8222326
https://www.nature.com/articles/s41467-021-23998-w and https://vimeo.com/578167974

Liu Q, Sarrami-Foroushani A, Wang Y, MacRaild M, Kelly C, Lin F, Xia Y, Song S, Ravikumar N, Patankar T, Taylor ZA, Lassila T, Frangi AF. Hemodynamics of thrombus formation in intracranial aneurysms: An in silico observational study. APL Bioeng. 2023 Jul 7;7(3):036102. doi: 10.1063/5.0144848. https://pubs.aip.org/aip/apb/article/7/3/036102/2900843/Hemodynamics-of-thrombus-formation-in-intracranial

Redrup E, Mitchell C, Myles P, Branson R, Frangi AF. Cross-Regulator Workshop: Journeys, experiences and best practices on computer modelled and simulated regulatory evidence— Workshop Report [Internet]. InSilicoUK Pro-Innovation Regulations Network; 2023 [cited 2024 Sep 16]. Available from: https://zenodo.org/records/10121103

Frangi AF, Denison T, Myles P, Ordish J, Brown P, Turpin R, Kipping M, Palmer M, Flynn D, Afshari P, Lane C, de Cunha M, Horner M, Levine S, Marchal T, Bryan R, Tunbridge G, Pink J, Macpherson S, Niederer S, Shipley R, Dall’Ara E, Maeder T, Thompson M. Unlocking the power of computational modelling and simulation across the product lifecycle in life sciences: A UK Landscape Report [Internet]. Zenodo; 2023 [cited 2024 Sep 16]. Available from: https://zenodo.org/records/8325274 and https://vimeo.com/894224258

Podcast: Play in new window | Download (Duration: 36:46 — 50.5MB) | Embed

Subscribe: Email | RSS

This video is part of a series of guest expert interviews that we recorded for our new Yale Certificate Program on Medical Software and Medical AI – https://online.yale.edu/medical-software-ai-program.

Our guest is Dr. Vishisht Mehta who is the Director of Interventional Pulmonology at the Lung Center of Nevada, a division of Comprehensive Cancer Centers and also the Department Chair of Pulmonology at MountainView Hospital, both in Las Vegas. He is fellowship trained in Interventional Pulmonology, which specializes in the minimally invasive diagnosis and treatment of lung conditions. His interest and expertise lies in the application of artificial intelligence in pulmonology. He is also the founder of the webpage Pulmonary.ai. The video was recorded on July 26, 2024.

00:10 Introduction
02:56 Dr. Mehta’s initial interactions with AI vendors.
06:15 A doctor’s experience talking to engineers.
10:15 Where will we be in 5 years?
13:23 Patients’ reaction to the use of AI.
17:05 Training doctors to use AI
19:58 Presenting results to patients
22:40 Integrating AI technology into healthcare provider systems
30:27 Concerns
35:50 Concluding thoughts

Links:Pulmonary.AI

Podcast: Play in new window | Download (Duration: 43:01 — 59.1MB) | Embed

Subscribe: Email | RSS

Our guest is Riccardo Lampariello, who is a statistician by training and brings almost 25 years of experience in health. He initially spent 10 years in the pharmaceutical industry and then moved into the not-for-profit sector: GAVI, UICC and Terre des hommes. In 2022 he joined D-tree as their CEO. D-tree’s mission is to expand access to high-quality, essential healthcare by enabling better decision making.

His experience includes clinical operations, portfolio management, business development, capacity building, and public health. In the last 10 years, he has focused on adapting digital health solutions to the unique contexts of developing countries and scale them successfully to national level in Burkina Faso, India and Zanzibar. He also acquired substantial experience on data governance. He holds a MSc in Statistics and a MBA specialized in not-for-profit.

The interview was recorded on May 17th, 2024.

Further Reading and Links

The BBC video embedded in this interview can be found at: https://www.bbc.com/storyworks/healthier-together/how-tanzania-is-tackling-the-healthcare-gap

A video jointly produced by Yale BIDS and D-Tree on their work in Zanzibar can be found at: https://youtu.be/2i4baqXzapw?feature=shared
You can learn more about D-tree’s work: https://www.d-tree.org/

You can sign up to D-tree’s newsletter to stay up to date about their work: https://eepurl.com/dnYta5

WHO guidelines for chatbots for sexual and reproductive guidance https://iris.who.int/bitstream/handle/10665/376294/9789240090705-eng.pdf?sequence=1

Podcast: Play in new window | Download (Duration: 59:17 — 81.5MB) | Embed

Subscribe: Email | RSS

Our guest is Prof. Stephen Gilbert (https://www.linkedin.com/in/stephen-gilbert-31ba2587/) who is a Professor of Medical Device Regulatory Science at the Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden where he teaches and conducts research on regulatory science with a team of colleagues. He is also News and Views Editor, Nature Portfolio – Digital Health. He worked in senior MedTech and Digital Heath roles in industry for 5 years, before returning to academia in 2022.

His research goals are to advance the regulatory science of software as a medical device and AI-enabled medical devices. Innovative digital approaches to healthcare must be accompanied by innovative approaches in regulation to ensure speed to market, to maximum access of patients to life saving treatments whilst ensuring safety on market. His main research interests are in: (i) data sharing and the European Health Data Space; (ii) approaches to market approval of adaptive AI enabled medical devices; (iii) drugdigital/AI-enabled medical device product realisation; (iv) digital/virtual twins: as an organising concept of the future of healthcare.”

Further Reading

Derraz B, Breda G, Kaempf C, Baenke F, Cotte F, Reiche K, Köhl U, Kather JN, Eskenazy D, Gilbert S. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. NPJ Precis Oncol [Internet]. Nature Publishing Group; 2024 Jan 30 [cited 2024 Jan 30];8(1):1–11. Available from: https://www.nature.com/articles/s41698-024-00517-w
Gilbert S, Harvey H, Melvin T, Vollebregt E, Wicks P. Large language model AI chatbots require approval as medical devices. Nat Med [Internet]. Nature Publishing Group; 2023 Jun 30 [cited 2023 Jun 30];1–3. Available from: https://www.nature.com/articles/s41591-023-02412-6

Gilbert S and Kather JN. Guardrails for the use of generalist AI in cancer care. Nature Reviews Cancer [Internet]. Nature Publishing Group; 2024 Apr 16 [cited 2024 Apr 16]. Available from: https://www.nature.com/articles/s41568-024-00685-8

Podcast: Play in new window | Download (Duration: 26:11 — 24.0MB) | Embed

Subscribe: Email | RSS

Our guest is Mr. Hirohito Okuda. Mr Okuda has close to 30 years of working experience in the medical device industry. Currently he is a principal AI engineer at Konica Minolta, Japan where he directs AI engineering across the company, leads generative AI adaptation, helps to establish AI guidelines and is also a member of the AI ethics review committee that reviews all AI products across the company. Prior to that, he was for 2 years an AI R&D division manager at DeNa and for 10 years prior he was a software engineering division manager at General Electric, Japan. Before that, he spent two years as a research software engineer at Yale. The interview was recorded on Dec 6, 2023.

Podcast: Play in new window | Download (Duration: 26:59 — 24.9MB) | Embed

Subscribe: Email | RSS

Our guest is Mr. Bernhard Kappe (https://www.linkedin.com/in/bernhardkappe/) who is the founder and CEO of Orthogonal (https://orthogonal.io/), a medical device consulting company. He is also a member of the AAMI working group AAMI SW WG-10 Cloud Computing. This interview was recorded on Nov 16, 2023.

Further Reading:
Kappe B. Accelerating Medical Product Development: Applying Agile Methods to Shorten Timelines, Reduce Risk and Improve Quality [Internet]. Orthogonal; 2020. Available from: https://orthogonal.io/insights/agile/ebook-agile-in-an-fda-regulated-environment/
Association for the Advancement of Medical Instrumentation (AAMI). AAMI TIR45: 2023; Guidance on the use of agile practices in the development of medical device software. Arlington VA: Association for the Advancement of Medical Instrumentation; 2023. Report No.: TIR45. https://webstore.ansi.org/standards/aami/aamitir452012r2018?gad_source=1

Agile Lego Game:
https://www.youtube.com/watch?v=0lA00lDs_R4
https://www.youtube.com/watch?v=7BKPDScVb5U

Podcast: Play in new window | Download (Duration: 36:36 — 50.3MB) | Embed

Subscribe: Email | RSS

Our guest is Mr Larkin Lowrey (https://www.linkedin.com/in/larkinlowrey/). Mr Lowrey has spent the past 30 years in the Software Engineering Product Development space building new product development organizations but also turning around organizations which had fallen into traps resulting in poor quality, execution and products which did not resonate in the marketplace. Most of his career has been in IoT and, notably, he built a telematics platform that was sold to Verizon and now operates as Verizon Networkfleet. Recently he moved into MedTech. He states that there is a lot of overlap between these areas given how medical devices, sensors increasingly make heavy use of cloud analytics platforms. This interview was recorded on Dec
7, 2023.

Further Reading/watching:
Webinar: Crossing the Chasm: Growing Tech Professionals into MedTech Professionals | Orthogonal: https://www.youtube.com/watch?v=nB645qIuLFA
Code Generation AI:
• Github Copilot: https://github.com/features/copilot
Image Generation AI:
• Midjourney https://www.midjourney.com/
• DALL·E https://openai.com/research/dall-e

Podcast: Play in new window | Download (Duration: 42:03 — 57.8MB) | Embed

Subscribe: Email | RSS

Our guest is Prof. Anat Lior (https://drexel.edu/law/faculty/fulltime_fac/Anat%20Lior/) who is an assistant professor at Drexel University’s Thomas R. Kline School of Law, an AI Schmidt affiliated Scholar with the Jackson School at Yale and an affiliated fellow at the Yale Information Society Project. Her research interests include AI governance and liability, quantum computing policy, and the intersection of insurance and emerging technologies. The interview was recorded on Dec 5, 2023.

Further Reading:
EU AI Act: https://artificialintelligenceact.eu/the-act/
Biden AI Executive Order: https://www.whitehouse.gov/briefing-room/presidential-actions/2023/10/30/executive-order-on-the-safe-secure-and-trustworthy-development-and-use-of-artificial-intelligence/
Lior A. Insuring Ai: The role of insurance in artificial intelligence regulation. Harv J Law Technol. 2002;35(2):467–530. Available from: https://jolt.law.harvard.edu/assets/articlePDFs/v35/2.-Lior-Insuring-AI.pdf